>
Organization
Vectura Group Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Vectura Group Plc

... Pharmaceutical firm Vectura has announced it expects its core profits to be "materially above" current ...
... revealed it is moving its headquarters to London's White City Place, and Vectura stopped work on its nebulized formulation of budesonide following a phase 3 ...
... PHARMA company Vectura has taken a £40m hit after one of its clinical trials for ...
... drug candidate, a treatment for obesity related to a rare disorder. U.K.'s Vectura ditches asthma drug. Another clinical debacle on the horizon: U.K.-based Vectura's shares ...
... A phase 3 trial of Vectura's VR475 in patients with severe uncontrolled asthma has missed its primary endpoint. ...
... UK-based drug manufacturers Vectura Group and Hikma Pharmaceuticals have collaborated to develop and commercialise a generic ...
... Vectura Group announces global agreement with Hikma to develop generic versions of GSK's ...
... Chippenham - Vectura Group plc (LSE: VEC) ('Vectura' or 'the Group') announces its unaudited Interim Results ...
... Vectura unveiled positive results from two phase 2 studies evaluating the ability of ...
... Vectura Group plc (LSE: VEC) notifies that the Company's issued share capital as at 30 ...
Subscribe now for full coverage on Vectura Group Plc
Start My Free Trial